2021-11-16-世界卫生组织-Cervical_cancer_Iraq_2021_country_profile_1页_63kb

Cervical cancer in Iraq presents a significant public health challenge, with high morbidity and mortality rates highlighted by 70,000 female deaths in 2019, indicating a substantial burden. Prevention efforts are insufficient, as HPV vaccination coverage is only 2% of the target population, and the HPV vaccine is not included in the national vaccination schedule. Secondary prevention screening is inadequate, with no national program and only about 12% of women ever screened in certain age groups. Treatment is supported by guidelines, but resources are limited, as evidenced by quantities like radiotherapy units. Data on key indicators such as incidence rates and mortality-to-incidence ratio are incomplete or not fully specified, and Iraq is not on track to meet WHO elimination targets for cervical cancer by 2030, due to underfunded or absent prevention and screening initiatives. Risk factors like tobacco use and HIV incidence are documented but not fully detailed, adding to the challenges.